Literature DB >> 17255822

The grown-up congenital cardiac patient.

Adele Borghi1, Matteo Ciuffreda, Maria Quattrociocchi, Laura Preda.   

Abstract

Long-term survival of patients with congenital heart disease has dramatically improved during the last 50 years and the number of adults with congenital heart disease is therefore increasing in all developed countries. Grown-up patients with congenital heart disease (GUCH) often present difficult and challenging problems. Patients with both native unoperated and operated malformations contribute to the GUCH population. Survivors without surgical treatment mainly have simple malformations; but a few have complex diseases, and some have survived with secondary pulmonary hypertension. Among operated malformations there are patients with a 'complete' repair (anatomical and physiological), others with a definitive palliation (physiological repair) and some with a simple palliation. The clinical spectrum is obviously diversified, depending on the underlying anomaly, surgical outcome, presence of residua, sequelae and/or complications, length of follow-up, comorbidities. Arrhythmias, bacterial endocarditis, cyanosis, polycythemia, heart failure, anomalies of pulmonary circulation, deterioration or malfunction of devices, need of cardiac and non-cardiac surgery, intercurrent non-cardiac diseases, and a need for cardiac and non-cardiac diagnostic procedures are common problems of adults with congenital heart disease. Physiological events such as pregnancy and childbearing deserve a careful multidisciplinary approach. While most simple native and well corrected GUCH do not require very specialized treatments throughout their life, the abnormalities and complexities of postoperative anatomy are often beyond the expertise of the adult cardiologist, requiring multidisciplinary competence in specialized tertiary centers. The problem is still unresolved and involves cultural, medical, technological and economically relevant issues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255822     DOI: 10.2459/01.JCM.0000247441.79644.4b

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  3 in total

1.  Advanced therapies in patients with congenital heart disease-related pulmonary arterial hypertension: results from a long-term, single center, real-world follow-up.

Authors:  Silvia Favilli; Gaia Spaziani; Piercarlo Ballo; Veronica Fibbi; Gennaro Santoro; Enrico Chiappa; Chiara Arcangeli
Journal:  Intern Emerg Med       Date:  2015-01-09       Impact factor: 3.397

2.  Extracorporeal membrane oxygenation in adult patients with congenital heart disease.

Authors:  R J Uilkema; L C Otterspoor
Journal:  Neth Heart J       Date:  2014-11       Impact factor: 2.380

Review 3.  Say NO to ROS: Their Roles in Embryonic Heart Development and Pathogenesis of Congenital Heart Defects in Maternal Diabetes.

Authors:  Anish Engineer; Tana Saiyin; Elizabeth R Greco; Qingping Feng
Journal:  Antioxidants (Basel)       Date:  2019-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.